Tilray is a global leader in medical cannabis production and research dedicated to providing safe, consistent and reliable therapy to patients. Our flagship facility in Nanaimo, B.C., is GMP-certified, producing medical cannabis in whole flower, cannabis oil and capsules to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.
In Canada, Tilray supports clinical trials focused on pediatric epilepsy at SickKids Hospital, post-traumatic stress disorder at the University of British Columbia, and chronic obstructive pulmonary disease at McGill University Health Centre. In Australia, Tilray has partnered with the University of Sydney and New South Wales Government to study medical cannabis as a treatment for symptoms of chemotherapy-induced nausea and vomiting. We plan to announce additional research partnerships in the new year.
We are committed to helping patients by providing excellent customer service. Our bilingual Patient Services team is available 24/7 to provide information and answer questions on Tilray products. Our national network of clinic partnerships helps connect patients and health-care providers with the latest information and research. Tilray. Improving lives through medical cannabis.